Isolated CD39 Expression on CD4+ T Cells Denotes both Regulatory and Memory Populations - American Journal of Transplantation
Frontiers | What Else Can CD39 Tell Us?
Adenosine-generating ovarian cancer cells attract myeloid cells which differentiate into adenosine-generating tumor associated macrophages – a self-amplifying, CD39- and CD73-dependent mechanism for tumor immune escape | Journal for ImmunoTherapy of Cancer
Blocking Antibodies Targeting the CD39/CD73 Immunosuppressive Pathway Unleash Immune Responses in Combination Cancer Therapies - ScienceDirect
ENTPD1/CD39 is a promising therapeutic target in oncology | Oncogene
CD39 is upregulated during activation of mouse and human T cells and attenuates the immune response to Listeria monocytogenes | PLOS ONE
CD39, His-Tag (Human) Recombinant
Phenotypical analysis of ectoenzymes CD39/CD73 and adenosine receptor 2A in CD4+CD25highFoxp3+ regulatory T‐cells in psoriasis - Han - 2018 - Australasian Journal of Dermatology - Wiley Online Library
Targeting CD39 in cancer | Nature Reviews Immunology
Stem-like TILs clean up your ACT
Expression of CD39 on Activated T Cells Impairs their Survival in Older Individuals - ScienceDirect
The expression of the adenosine pathway markers CD39 and CD73 in salivary gland carcinomas harbors the potential for novel immune checkpoint inhibition | SpringerLink
The expression of the adenosine pathway markers CD39 and CD73 in salivary gland carcinomas harbors the potential for novel immune checkpoint inhibition | SpringerLink
JCI Insight - PD-1 blockade restores helper activity of tumor-infiltrating, exhausted PD-1hiCD39+ CD4 T cells